3-异硫氰酸戊酯 | 201224-89-7

• 分子结构分类: 有机化合物 - 有机硫化合物 - 异硫氰酸盐
• 中文名称: 3-异硫氰酸戊酯
• 英文名称: 3-isothiocyanatopentane
• 英文别名: 3-pentyl isothiocyanate
• CAS: 201224-89-7
• 化学式: C₆H₁₁NS
• 分子量: 129.226
• InChiKey: YDRYFNXKCXDLPP-UHFFFAOYSA-N

物化性质

• 沸点：
  90°C 25mm
• 密度：
  0,92 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  44.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT-HARMFUL
• 危险品运输编号：
  UN 2810
• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  3-异硫氰酸戊酯 在 N,N-二甲基甲酰胺 、 三氯氧磷 作用下， 以 四氢呋喃 为溶剂， 反应 33.0h， 生成 N-(pentan-3-yl)-4,5-dihydro-1,3-thiazol-2-amine
  参考文献：
  名称：

  Synthesis and spectroscopic analysis of substituted 2-aminothiazolines

  摘要：

  2-Aminothiazolines can exist in two tautomeric species, amino and imino forms, which can theoretically exist as two stereoisomers. Several methods and techniques have been used to evaluate tautomeric process, but in this case N-15 NMR spectroscopy was used due to tautomeric process involves two nitrogen atoms. In this paper, we present the synthesis and a HMBC H-1-N-15 study of four 2-substituted aminothiazolines. It was observed from HMBC contour plot correlation between five membered ring CH2 groups with sp(2) nitrogen around 250 ppm, while aliphatic hydrogen correlates with sp(3) nitrogen around 90 ppm, suggesting that amino form is the major or the unique tautomer present in solution. Theoretical calculations at the M06-2X/cc-pVDZ level were performed and indicated that amino tautomer is slightly more stable (similar to 1 kcal mol(-1)) than imino one. (C) 2012 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.molstruc.2012.12.031
• 作为产物：
  描述：

  3-氨基戊烷 以 二氯甲烷 为溶剂， 反应 0.41h， 生成 3-异硫氰酸戊酯
  参考文献：
  名称：

  微波直接合成异硫氰酸酯

  摘要：

  微波技术的应用允许完成从胺类合成异硫氰酸酯的新颖，通用，“绿色”的一锅操作规程。反应易于扩展并且在不消旋手性胺的情况下进行。在这些条件下，中间体二硫代氨基甲酸酯可分解为异硫氰酸酯，而无需任何其他脱硫剂。

  DOI：

  10.1002/ejoc.201900105

文献信息

• T3P® – A Benign Desulfurating Reagent in the Synthesis of Isothiocyanates
  作者：Tadeusz Gajda、Łukasz Janczewski、Anna Gajda、Sebastian Frankowski、Tomasz Goszczyński

  DOI：10.1055/s-0036-1591842

  日期：2018.3

  Abstract A number of alkyl, aryl and bifunctional isothiocyanates are obtained in moderate to high yields (41–94%) in a two-step, one-pot reaction of the parent primary amines or their salts with carbon disulfide, followed by reaction of the thus formed dithiocarbamates with T3P® (propane phosphonic acid anhydride) as a new and efficient desulfurating agent. A number of alkyl, aryl and bifunctional isothiocyanates

  摘要 在母体伯胺或其盐与二硫化碳的两步一锅反应中，以中等至高收率（41-94％）获得了许多烷基，芳基和双官能异硫氰酸酯。与T3P形成二硫代氨基甲酸酯®（丙烷膦酸酐）作为一种新的和有效的脱硫剂。 在母体伯胺或其盐与二硫化碳的两步一锅反应中，以中等至高收率（41-94％）获得了许多烷基，芳基和双官能异硫氰酸酯。与T3P形成二硫代氨基甲酸酯®（丙烷膦酸酐）作为一种新的和有效的脱硫剂。
• HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
  申请人：AMGEN INC.

  公开号：US20170320860A1

  公开（公告）日：2017-11-09

  Compounds of Formula I and Formula II, pharmaceutically acceptable salts thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

  公式I和公式II的化合物，其药用盐，上述任何一个的立体异构体，或它们的混合物是APJ受体的激动剂，可能用于治疗心血管和其他疾病。公式I和公式II的化合物具有以下结构： 其中变量的定义在此提供。
• 4,5-Dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
  申请人：Lange H.M. Josephus

  公开号：US20070142362A1

  公开（公告）日：2007-06-21

  This invention is directed to 4,5-dihydro-(1H)-pyrazole(pyrazoline) derivatives as cannabinoid CB 1 receptor modulators, to pharmaceutical compositions containing these compounds, to methods for the preparation of these compounds, methods for preparing novel intermediates useful for their synthesis, and methods for preparing compositions. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in disorders in which CB 1 receptors are involved, or that can be treated via manipulation of those receptors. The compounds have the general formula (I) wherein the symbols have the meanings given in the specification.

  这项发明涉及作为大麻素CB1受体调节剂的4,5-二氢-(1H)-吡唑烯(吡唑啉)衍生物，含有这些化合物的药物组合物，制备这些化合物的方法，用于制备其合成有用的新中间体的方法，以及制备组合物的方法。该发明还涉及这些化合物和组合物的用途，特别是它们在向患者施用以在涉及CB1受体的疾病中实现治疗效果，或者可以通过操纵这些受体来治疗的疾病中的用途。 这些化合物具有通式(I) 其中符号的含义如规范中所述。
• 1,2,4-benzothiadiazine derivatives, their preparation and use
  申请人：Novo Nordisk AIS

  公开号：US06242443B1

  公开（公告）日：2001-06-05

  1,2,4-Benzothiadiazine derivatives represented by formula wherein D, R1, R2, R3, R4, R5, R12, R13, R14, R15 are defined in the description, composition thereof and methods for preparing the compounds are described. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.

  1,2,4-苯并噻二嗪衍生物的化学式如下： 其中D，R1，R2，R3，R4，R5，R12，R13，R14，R15在描述中有定义，描述了其组成以及制备该化合物的方法。 这些化合物在治疗中枢神经系统、心血管系统、呼吸系统、消化系统和内分泌系统疾病方面具有用途。
• ORGANIC COMPOUNDS
  申请人：Nozulak Joachim

  公开号：US20090099199A1

  公开（公告）日：2009-04-16

  The invention relates to compound of the formula I wherein the substituents are as defined in the specification; in free base form or in acid addition salt form; to its preparation, to its use as medicament and to medicaments comprising it.

  这项发明涉及公式I的化合物 其中取代基如规范中定义；以自由碱形式或酸盐形式存在；其制备，用作药物以及包含它的药物。